Comparative Pharmacology
Head-to-head clinical analysis: HER STYLE versus IMPLANON.
Peer-Reviewed Evidence
Head-to-head clinical analysis: HER STYLE versus IMPLANON.
HER STYLE vs IMPLANON
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
HER STYLE is a hormonal contraceptive containing ethinyl estradiol and levonorgestrel. It inhibits ovulation by suppressing gonadotropin-releasing hormone (GnRH) from the hypothalamus, reducing follicle-stimulating hormone (FSH) and luteinizing hormone (LH) secretion. It also thickens cervical mucus to impede sperm penetration and alters endometrial lining to prevent implantation.
Etonogestrel, a progestin, binds to progesterone and androgen receptors, suppressing gonadotropin release (FSH, LH) and preventing ovulation. It also increases cervical mucus viscosity, impeding sperm penetration, and alters endometrial morphology.
Not applicable. HER STYLE is not a recognized pharmaceutical agent; no standard dosing available.
Insert 1 rod (68 mg etonogestrel) subdermally in the inner upper arm; replacement every 3 years.
None Documented
None Documented
Terminal half-life: 12 hours (range 10–14 hours). Clinical context: Allows twice-daily dosing; steady-state achieved in ~2.5 days.
Terminal elimination half-life is approximately 25-30 hours; significant interindividual variability
Renal: 70% unchanged; Fecal: 20% as metabolites; Biliary: 10%.
Metabolites primarily excreted in urine (approximately 50%) and feces (30-35%)
Category C
Category C
Contraceptive
Contraceptive